Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1976; 35(03): 592-597
DOI: 10.1055/s-0038-1647957
DOI: 10.1055/s-0038-1647957
Original Article
On the Value of the Activated Partial Thrombo-Plastin Time (APTT) in Monitoring Heparin Therapy
Further Information
Publication History
Received
25 September 1975
Accepted
20 December 1975
Publication Date:
02 July 2018 (online)
Summary
Of 1068 blood samples referred for evaluation of the haemostatic mechanism 135 contained heparin as judged by the polybrene titration method. Of the 57 samples with a heparin concentration in the defined therapeutic range, 65 per cent had APTT values in the “therapeutic range”. Of the samples from patients who had not received any anticoagulant, 213 (24 per cent) had prolonged APTT, and 48 of these samples had APTT values in the “therapeutic range” for heparin therapy. It is suggested that the APTT test is of limited value in monitoring heparin therapy.
-
References
- 1 Baele G, De Broe M, De Weerdt G. A, Ringoir S, Barbier F. 1972; Limitations of the activated partial thromboplastin time for determination of plasma heparin concentration and half-life in human subjects. Thrombosis 27: 107.
- 2 Basu D, Gallus A, Hirsh J, Cade J. 1972; A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. New England Journal of Medicine 287: 324.
- 3 Brozovic C, Stirling Y, Klenerman L, Lowe L. 1974; Subcutaneous heparin and postoperative thromboembolism. Lancet II: 99.
- 4 Czapek E. E. 1974; Iatrogenic prolonged APTT: A nondisease state. Journal of the American Medical Association 227: 1304.
- 5 Degnan T. J, Karasik S, Lenahan J. 1969; Laboratory control of heparin therapy with the activated partial thromboplastin time test. Current Therapeutic Research 11: 390.
- 6 Denson K. W. E, Bonnar J. 1973; The measurement of heparin. A method based on the potentiation of anti-factor Xa. Thrombosis et Diathesis Haemorrhagica 30: 471.
- 7 Dewhurst F, Poller L. 1965; Antiheparin activity of some human blood protein fractions and their possible relationship to thrombosis. Journal of Clinical Pathology 18: 339.
- 8 Godal H. C. 1960; A comparison of two heparin-neutralizing agents: Protamine and polybrene. Scandinavian Journal of Clinical and Laboratory Investigation 12: 446.
- 9 Godal H. C. 1961; Heparin tolerance and the plasma proteins. Scandinavian Journal of Clinical and Laboratory Investigation 13: 314.
- 10 Godal H. C, Gjengedal G. 1971; Activation of coagulation by heparin-protamine complexes as demonstrated by Thrombotest. Scandinavian Journal of Haematology 8: 194.
- 11 Grann V. R, Homewood K, Golden W. 1972; Polybrene neutralization as a rapid means of monitoring blood heparin levels. American Journal of Clinical Pathology 28: 26.
- 12 Hirsh J, Gallus A. S. 1973; Letter to the Editor. New England Journal of Medicine 288: 1410.
- 13 Korsan-Bengtsen K. 1971; Routine tests as measures of the total intrinsic blood clotting potential. Scandinavian Journal of Haematology 8: 359.
- 14 Marder V. J. 1970; A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy. Thrombosis et Diathesis Haemorrhagica 24: 230.
- 15 O’Shea M. J, Flute P. T, Panell G. M. 1971; Laboratory control of heparin therapy. Journal of Clinical Pathology 24: 542.
- 16 O’Sullivan E. F, Hirsh J, McCarthy R. A, De Gruchy G. C. 1968; Heparin in the treatment of venous thromboembolic disease: Administration, control and results. Medical Journal of Australia 2: 153.
- 17 Proctor R. R, Rapaport S. I. 1961; The partial thromboplastin time with kaolin. American Journal of Clinical Pathology 36: 212.
- 18 Salzman E. W, Deykin D, Shapiro R. M, Rosenberg R. 1975; Management of heparin therapy. Controlled prospective trial. New England Journal of Medicine 292: 1046.
- 19 Soloway H. B, Cornett B. M, Grayson Jr. J. W. 1973; Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy. American Journal of Clinical Pathology 59: 587.
- 20 Teien A. N, Lie M. 1975; Heparin assay in vitro: A comparison of five clotting assays. Thrombosis Research, 7: 777.
- 21 Yin E. T, Wessler S, Butler J. V. 1973; Plasma heparin: A unique, practical, submicrogram-sensitive assay. Journal of Laboratory and Clinical Medicine 81: 298.
- 22 Zucker S, Cathey M. H. 1969; Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin. Journal of Laboratory and Clinical Medicine 73: 320.